EDGAR Filing Documents for 0001144204-17-063250

Form 8-K - Current report:

SEC Accession No. 0001144204-17-063250

Filing Date

2017-12-12

Accepted

2017-12-12 09:28:03

Documents

Period of Report

2017-12-11

Items

Item 1.01: Entry into a Material Definitive Agreement
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq	Description	Document	Type	Size
1	8-K	tv481177_8k.htm	8-K	48352
2	EXHIBIT 2.1	tv481177_ex2-1.htm	EX-2.1	637577
3	EXHIBIT 4.1	tv481177_ex4-1.htm	EX-4.1	196281
4	EXHIBIT 4.2	tv481177_ex4-2.htm	EX-4.2	193766
5	EXHIBIT 4.3	tv481177_ex4-3.htm	EX-4.3	178683
6	EXHIBIT 4.4	tv481177_ex4-4.htm	EX-4.4	178830
7	EXHIBIT 10.1	tv481177_ex10-1.htm	EX-10.1	106604
8	EXHIBIT 99.1	tv481177_ex99-1.htm	EX-99.1	12397
9	GRAPHIC	tv481177_ex10-1logo.jpg	GRAPHIC	6005
10	GRAPHIC	tv481177_ex99-1img1.jpg	GRAPHIC	11285
	Complete submission text file	0001144204-17-063250.txt		1577960

Mailing Address 2408 TIMBERLOCH PLACE B-7 THE WOODLANDS TX 77380

Business Address 2408 TIMBERLOCH PL SUITE B-7 WOODLANDS TX 77380 2817193400

REPROS THERAPEUTICS INC. (Filer) CIK: 0000897075 (see all company filings)